Stock Markets May 11, 2026 02:34 AM

GEA posts stronger orders and EBITDA but sees cash flow slide; EPS below forecasts

German food and beverage equipment maker raises organic growth and margin metrics yet free cash flow and liquidity deteriorate in Q1 2026

By Jordan Park

GEA Group AG reported first-quarter 2026 results showing order intake and underlying operating profit above analyst consensus, while earnings per share missed estimates and free cash flow deteriorated sharply. The company confirmed its full-year 2026 guidance for organic sales growth, EBITDA margin and return on capital employed.

GEA posts stronger orders and EBITDA but sees cash flow slide; EPS below forecasts

Key Points

  • Order intake increased to 1.45 billion in Q1 2026, beating consensus and rising 2.8% year-on-year; organic order growth was 6.4%. - Impacts industrials and food processing equipment markets.
  • EBITDA before restructuring expenses rose to 205.9 million and the margin expanded to 16.2%, exceeding consensus. - Impacts profitability metrics for machinery and manufacturing sectors.
  • Free cash flow swung to negative 190.3 million and net liquidity dropped to 162.4 million, reflecting deterioration in cash generation. - Impacts corporate finance and credit considerations in capital-intensive sectors.

GEA Group AG reported mixed first-quarter 2026 results, with order intake and EBITDA before restructuring expenses coming in ahead of consensus, but earnings per share falling short of analyst expectations as cash generation weakened markedly. The German manufacturer of equipment for the food and beverage industry reaffirmed its full-year targets.

Orders and revenue

Order intake for the January-March period rose to 1.45 billion, exceeding the analyst consensus mean of 1.42 billion and up from 1.41 billion a year earlier. On an organic basis - excluding the effects of portfolio changes and currency translation - order intake grew 6.4%, accelerating from 3.4% in the first quarter of 2025.

Revenue reached 1.27 billion, matching the consensus mean of 1.27 billion and representing a 1.2% increase from the year-earlier period. Organic revenue growth was 5.3%, compared with 0.9% in Q1 2025.

Profitability and EPS

EBITDA before restructuring expenses increased 3.9% to 205.9 million, above the consensus mean of 205.2 million. The corresponding margin expanded by 42 basis points to 16.2% from 15.8% a year earlier, topping the consensus mean of 16.1%.

Earnings per share were 0.61, below the consensus mean of 0.63. On a before-restructuring basis, earnings per share were 0.64, up from 0.62 in the year-ago quarter.

Cash flow and liquidity

Free cash flow moved sharply into negative territory, falling to negative 190.3 million from negative 48.8 million a year earlier. Cash flow from operating activities was negative 124.7 million versus negative 17.8 million in Q1 2025, while cash flow from investing activities was negative 65.6 million compared with negative 31 million a year earlier.

Net liquidity decreased to 162.4 million from 378.9 million at December 31, 2025.

Backlog and divisional performance

The order backlog stood at 3.50 billion as of March 31, up 8.1% from 3.24 billion a year earlier. The book-to-bill ratio improved to 1.14 from 1.12.

Division-level results were mixed. Farm Technologies posted the strongest revenue increase among GEA's divisions, with revenue up 21.3% to 202 million and organic growth of 26%. By contrast, Nutrition Plant Engineering revenue declined 7.8% to 399.5 million, with organic revenue down 4.8%; EBITDA before restructuring expenses in that division fell 20.8% to 31.8 million.

Geopolitical note and guidance

The company said the Iran conflict, which began in February 2026, had "no noticeable impact on business performance" in the quarter.

GEA confirmed its full-year 2026 outlook, targeting organic sales growth of 5% to 7%, an EBITDA margin before restructuring expenses of 16.6% to 17.2%, and a return on capital employed of 34% to 38%.


Analysis: The quarter shows momentum in orders and margin expansion, while working capital and cash flow dynamics caused a material deterioration in liquidity. Division-level contrasts highlight areas of acceleration and weakness within the business. The company maintained its published full-year financial targets.

Risks

  • Sharp deterioration in free cash flow and lower net liquidity create financing and operational risks for the company. - This affects investors focused on industrials and capital goods.
  • Nutrition Plant Engineering showed weaker revenue and a 20.8% decline in EBITDA before restructuring expenses, indicating division-level margin pressure. - This presents execution risk within the food processing equipment segment.
  • Geopolitical uncertainty remains a potential source of disruption even though the company reported the Iran conflict had "no noticeable impact on business performance" in the quarter. - This could affect supply chains and international operations within the broader industrial and food sectors.

More from Stock Markets

Nvidia CEO Jensen Huang Sees 27% Drop in Total Pay as Stock Awards Lose Value May 12, 2026 Activist Urges BWX Technologies to Revisit Shelved Reactor Plan, Sees Potential for Stock to Double May 12, 2026 S&P Moves Mexico’s Outlook to Negative, Citing Fiscal Strain and Tepid Growth May 12, 2026 Moody's Lowers Everforth Outlook to Negative Amid Elevated Leverage May 12, 2026 Moody's Moves Albemarle Outlook to Stable After Debt Cuts and Stronger Lithium Prices May 12, 2026